Henry ScheinHSIC -0.14%79 ROC (Joel Greenblatt) % is 25.09% as of Mar. 2026, which is 17% below its 10-year median of 30.15. GuruFocus rates HSIC with a GF Score™ of 79/100 and a GF Value™ of $83.79 (Fairly Valued). The stock has 9 warning signs investors should review. Among 118 Medical Distribution companies, Henry Schein ranks better than 60.17% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Henry Schein's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 25.09%.
The historical rank and industry rank for Henry Schein's ROC (Joel Greenblatt) % or its related term are showing as below:
HSIC'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 22.94 Med: 30.15 Max: 45.36
Current: 23.22
During the past 13 years, Henry Schein's highest ROC (Joel Greenblatt) % was 45.36%. The lowest was 22.94%. And the median was 30.15%.
HSIC's ROC (Joel Greenblatt) % is ranked better than 60.17% of 118
companies
in the Medical Distribution industry
Industry Median: 15.345
vs HSIC: 23.22
Henry Schein's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -7.60% per year.
Henry Schein (NAS:HSIC) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Henry Schein ROC (Joel Greenblatt) % Related Terms
Henry Schein ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Henry Schein's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HSIC vs AHG, ACH, FOCL: ROC (Joel Greenblatt) % Comparison
For the Medical Distribution subindustry, Henry Schein's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Henry Schein ROC (Joel Greenblatt) % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Henry Schein's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Henry Schein's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 25.09% mean?
Henry Schein (HSIC) has a ROC (Joel Greenblatt) % of 25.09% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Henry Schein and its competitors. This is 17% below median its historical median of 30.15. Over the past decade, Henry Schein's ROC (Joel Greenblatt) % has ranged from 22.94 to 45.36. According to the industry distribution chart, Henry Schein ranks #47 out of 118 companies in the Medical Distribution industry, placing it in the top 39.8%.
Is Henry Schein's ROC (Joel Greenblatt) % too high?
Henry Schein's current ROC (Joel Greenblatt) % of 25.09% is 17% below median its 10-year median of 30.15. Over the past 10 years, this metric has ranged from a low of 22.94 to a high of 45.36. The Medical Distribution industry median ROC (Joel Greenblatt) % is 15.35. Henry Schein's value of 25.09% is 63.5% above this industry median. Based on the distribution chart, Henry Schein ranks #47 out of 118 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Henry Schein has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henry Schein's ROC (Joel Greenblatt) % compare to AHG and ACH?
According to the Medical Distribution industry distribution chart, Henry Schein ranks #47 out of 118 companies for ROC (Joel Greenblatt) %. This puts Henry Schein in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 15.35. Henry Schein's value of 25.09% is 63.5% above this benchmark. Historically, Henry Schein's own ROC (Joel Greenblatt) % has ranged from 22.94 to 45.36 over the past decade. While the company's 10-year median is 30.15 vs. the industry median of 15.35, Henry Schein has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Distribution company?
The median ROC (Joel Greenblatt) % among Medical Distribution companies is 15.35, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Henry Schein's current ROC (Joel Greenblatt) % of 25.09% is 63.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Henry Schein and its competitors. For the Medical Distribution industry, the median ROC (Joel Greenblatt) % is 15.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Henry Schein's current ROC (Joel Greenblatt) % is 25.09%, which is 17% below median its own 10-year median of 30.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henry Schein stock overvalued right now?
Based on GuruFocus' analysis, Henry Schein (HSIC) is currently considered Fairly Valued. The stock's GF Value™ is $83.79, compared to a current price of $86.31 — trading 3% above its estimated fair value. The current ROC (Joel Greenblatt) % is 25.09%, which is 17% below median its 10-year median of 30.15 and 63.5% above the Medical Distribution industry median of 15.35. Henry Schein's overall GF Score™ is 79/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Henry Schein (HSIC), the current ROC (Joel Greenblatt) % is 25.09% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Henry Schein (HSIC) Overvalued in 2026?
Based on GuruFocus' analysis, Henry Schein stock appears to be overvalued.
The current stock price of $86.31 is trading 3% above its estimated GF Value™ of $83.79.
GuruFocus considers Henry Schein to be Fairly Valued.
Key valuation signals for HSIC:
ROC (Joel Greenblatt) %: 25.09% (17% below median its 10-year median of 30.15)
GF Value™: $83.79 vs. price of $86.31 (3% above fair value)
Industry Position: 63.5% above the Medical Distribution median (#47 of 118)
No single metric tells the full story. See the HSIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
79GF Score
Get the complete analysis for HSIC
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSIC has been successfully added to your 
